NF1 and neoplasm: DAPI+ nuclei containing detectable, activated (nuclear) p65 represented 2.22% ± 0.33% of tumor cells, and, of GFP+Nf1-mutant SCs, 7.12% ± 1.15% of mutant SCs do so.